Trials / Unknown
UnknownNCT01373801
Hemcon© Bandage for Postpartum Bleeding Due to the Multiple Vaginal Lacerations
THE EFFICACY AND SAFETY OF HEMCON© BANDAGE FOLLOWING SURGICAL REPAIR IN MANAGEMENT OF POSTPARTUM BLEEDING DUE TO THE MULTIPLE VAGINAL LACERATIONS
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (estimated)
- Sponsor
- Soroka University Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to assess the safety and efficacy of the HemCon GuardaCareXR compared to standard bandaging in subjects with post partum hemorrhage as a result of cervical and vaginal lacerations. The primary endpoint will be a cessation of bleeding at 30 minutes after insertion of the dressing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | The HemCon GuardaCare | The HemCon GuardaCare (HemCon Medical Technologies Inc., Portland, OR) is a hemostatic dressing made of chitosan, a complex carbohydrate derived from chitin from shellfish and is designed as a hemostatic dressing, and a topical antimicrobial dressing. GuardaCare contains no pro-clotting agents, providing a safe and localized hemostatic solution and is latex free and sterile. |
| DEVICE | Control | Standard packing gauze roll bandage. |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-07-01
- First posted
- 2011-06-15
- Last updated
- 2011-08-10
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01373801. Inclusion in this directory is not an endorsement.